Are there treatments specifically for BRCA1-related cancers?
Yes, there are targeted therapies available for cancers related to BRCA1 mutations. One example is PARP inhibitors, which are a type of drug that targets cancer cells with defective DNA repair mechanisms. These drugs have shown promise in treating BRCA1-related breast and ovarian cancers by exploiting the cells' inability to repair DNA, leading to cell death.